首页> 外文期刊>Online journal of biological sciences >Modulation of IFN-γ, IL-4 and IL-17 Cytokines is Related to Parasitemia Control in Mice Infected by Trypanosoma cruzi and Treated with Biotherapy | Science Publications
【24h】

Modulation of IFN-γ, IL-4 and IL-17 Cytokines is Related to Parasitemia Control in Mice Infected by Trypanosoma cruzi and Treated with Biotherapy | Science Publications

机译:克氏锥虫感染并用生物疗法治疗小鼠中的寄生虫控制与IFN-γ,IL-4和IL-17细胞因子的调节有关|科学出版物

获取原文
       

摘要

> >The study of biotherapies as an intervention in experimental models of infection is a possible means to understand the effects of these highly diluted medications. The present study evaluated the immunological and parasitological effects of biotherapies that were prepared from mouse serum that was uninfected (sarcode: BSNI13cH group) and chronically infected with the Y strain of T. cruzi (nosode: BSI13cH group), dynamization 13cH, in male Swiss mice at 28 days of age. On days 0 and 12 after infection (a.i.), the BSNI13cH group exhibited a pronounced Th1 response that was attributable to a reduction of interleukin-4 (IL-4) concentrations, with no significant differences in interferon-γ (IFN-γ) concentrations and a decrease in IL-17A concentrations on day 0 a.i. compared with the control and BSI13cH groups. However, this cytokine balance was not sufficient to alter blood parasitemia in treated animals, likely because of a decrease in IFN-γ concentrations on day 8 a.i., thus hindering a more effective Th1 response. In contrast, the BSI13cH group presented a pronounced Th2 response that was attributable to an increase in IL-4 concentrations (on days 0 and 8 a.i.) and a decrease in IFN-γ concentration (on day 12 a.i.) compared with the control and BSNI13cH groups. This cytokine balance suppressed the immune response to T. cruzi in murine infection, resulting in a significant increase in blood parasitemia, decrease in the patent period and subsequently a decrease in survival time. The results indicate that these highly diluted medications differentially modulate the immune system and represent a substantial contribution to the field of homeopathic medicine, providing evidence of the action of these medications
机译: > >研究生物疗法作为感染实验模型的一种干预手段,可能是了解这些高度稀释的药物作用的一种可能方法。本研究评估了由未感染的小鼠血清(sarcode:BSNI 13cH 组)并长期感染了 T的Y菌株制备的生物疗法的免疫学和寄生虫学效果。在28日龄的雄性瑞士小鼠中,将cruzi (结节:BSI 13cH 组)动态化13cH。感染后第0天和第12天(ai),BSNI 13cH 组显示出明显的Th1反应,这归因于白细胞介素4(IL-4)浓度的降低,干扰素无明显差异第0天ai-γ(IFN-γ)浓度和IL-17A浓度降低与对照组和BSI 13cH 组相比。然而,这种细胞因子的平衡不足以改变治疗动物的血液寄生虫病,可能是因为在第8天(a.i.)IFN-γ浓度降低,从而阻碍了更有效的Th1反应。相比之下,BSI 13cH 组表现出明显的Th2反应,这归因于IL-4浓度升高(在第0和8 ai天)和IFN-γ浓度降低(在第12天)。 ai)与对照组和BSNI 13cH 组进行比较。这种细胞因子平衡抑制了对T的免疫反应。 Cruzi 在鼠类感染中的发生,导致血液寄生虫病显着增加,专利期缩短,随后生存时间减少。结果表明,这些高度稀释的药物会差异性地调节免疫系统,并在顺势疗法领域发挥了重要作用,为这些药物的作用提供了证据

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号